Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recurrence × Thalidomide × Clear all

Phase

Phase 2 8 Phase 3 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Waldenstrom Macroglobulinemia 1 Stomach Neoplasms 1 Recurrence 1 Neoplasms, Second Primary 1 Neoplasms 1 NSCLC 1 Lymphoma, Mantle-Cell 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

Brentuximab Vedotin 3 relmacabtagene autoleucel 2 fludarabine phosphate 2 fludarabine 2 Cytarabine 2 Bortezomib 2 Antilymphocyte Serum 2 xihuang 1 tocilizumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 sintilimab 1 rasburicase 1 ledipasvir 1 entecavir 1 apatinib 1 aflibercept 1 acalabrutinib 1 Urate Oxidase 1 Trabectedin 1 Thiotepa 1 Thalidomide 1 Tenofovir 1 Tamsulosin 1 Sofosbuvir 1 Sevoflurane 1 Rivaroxaban 1 Ribavirin 1 Radiotherapy 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00652041 2011-09-19

TaCyDexVMP7

PETHEMA Foundation

Phase 4 Completed

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡